Gene structure and chromosomal localization of mouse Opa1 : its exclusion from the Bst locus by Delettre, Cécile et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Genetics
Open Access Research article
Gene structure and chromosomal localization of mouse Opa1 : its 
exclusion from the Bst locus
Cécile Delettre*1, Guy Lenaers2, Pascale Belenguer2 and Christian P Hamel1
Address: 1Inserm U. 254 71, rue de Navacelles 34090 Montpellier France and 2CNRS UMR 5088 Laboratoire de Biologie Cellulaire et Moléculaire 
du Contrôle de la Prolifération Université Paul Sabatier, Bâtiment IVR3-B1 118, route de Narbonne 31062 Toulouse cedex 4 France
Email: Cécile Delettre* - delettre@pasteur.fr; Guy Lenaers - glen@cict.fr; Pascale Belenguer - belengue@cict.fr; 
Christian P Hamel - hamel@montp.inserm.fr
* Corresponding author    
Abstract
Background: Autosomal dominant optic atrophy type 1 (DOA) is the most common form of
hereditary optic atrophy in human. We have previously identified the OPA1 gene and shown that it
was mutated in patients with DOA. OPA1 is a novel member of the dynamin GTPase family that
play a role in the distribution of the mitochondrial network. The Bst (belly spot and tail) mutant
mice show atrophy of the optic nerves and previous mapping data raise the possibility that Bst and
OPA1 are orthologs. In order to analyse the Bst mouse as a model for DOA, we therefore
characterized mouse Opa1 and evaluated it as a candidate for the Bst mutant mouse.
Results: Comparison of mouse and human OPA1 sequences revealed 88% and 97% identity at the
nucleotide and amino acid levels, respectively. Presence of alternatively spliced mRNAs as seen in
human was conserved in the mouse. Screening of the whole mRNA coding sequence and of the 31
exons of Opa1 did not reveal any mutation in Bst. Using a radiation hybrid panel (T31), we mapped
Opa1 to chromosome 16 between genetic markers D16Mit3 and D16Mit124, which is 10 cM
centromeric to the Bst locus.
Conclusion: On the basis of these results we conclude that Opa1 and Bst are distinct genes and
that the Bst mouse is not the mouse model for DOA.
Background
Autosomal dominant optic atrophy (DOA), Kjer type [1],
is the most common form of hereditary optic neuropa-
thies with an estimated prevalence of 1:50 000 in most
populations [2] and prevalence as high as 1:10 000 in
Denmark [3]. The disease appears with an insidious onset
of variable visual loss, optic nerve pallor, caecocentral vis-
ual field scotoma, and color vision deficit. Histopatholog-
ical [4,5] and electrophysiological [6,7] studies suggest
that the underlying defect is a retinal ganglion cell degen-
eration. Most families of DOA have been shown to map
to 3q28-29 (OPA1, MIM 165500) [8–14]. The gene
named OPA1 was subsequently identified [15,16] with
more than 70 mutations described today [17–21]. One
single family was found to determine a second locus
(OPA4, MIM 605293) at 18q12.2-q12.3 [22]. OPA1 codes
a mitochondrial dynamin-related GTPase that may play a
role in the maintenance of mitochondrial morphology
and DNA. Tissue specific expression of OPA1 alternatively
spliced exons may underlie some specific neuronal re-
quirements in OPA1 [18].
In 1977, Southard et al. [23] identified a dominant muta-
tion, belly spot and tail (Bst), which arose spontaneously
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in the C57BLKS mouse strain with in utero death of ho-
mozygotes. Heterozygous mice have a kinky tail, white
feet and white spots at the ventral midline. In addition,
approximately 50% of the Bst/+ mice, show a reduction or
a complete absence of the pupillary light reflex in one or
both eyes [24]. This neurological phenotype is associated
with unilateral or bilateral atrophy of the optic nerves. The
severity of the atrophy of the optic nerves is highly varia-
ble ranging from a slight reduction in the number of gan-
glion cell axons in only one optic nerve to a complete
elimination of both optic nerves. This is reminiscent of
the human situation in which DOA patients show varia-
ble expression ranging from asymptomatic carriers to pa-
tients with legal blindness. The aspect of the retinal
surface and the appearance of the inner and outer nuclear
layers in Bst/+ mice are qualitatively normal [24]. Howev-
er, the ganglion cell numbers appear to be reduced be-
cause of a failure of the ganglion cell axons to reach the
optic nerve head in early development [25].
The Bst gene is located on mouse chromosome 16 in a re-
gion that is partially conserved on human chromosome
3q28-qter [26–28]. Based on its reported mapping to the
syntenic region of OPA1 and on some phenotypic similar-
ities of the Bst mouse and human DOA, the Bst gene could
be the murine ortholog of OPA1, and therefore the Bst
mouse could be proposed as a model for DOA. To address
this question we determined the Opa1 gene sequence in-
cluding its promoter region, as well as its chromosomal
localization and that of the markers of the Bst interval. Ab-
sence of mutations in the mouse gene and distinct locali-
zation of Opa1 and Bst definitely excludes Opa1 as the
gene responsible for the Bst phenotype.
Results and Discussion
cDNA sequence and gene structure of mouse Opa1
In a previous study we isolated OPA1 [15], a human dy-
namin-related protein mutated in DOA. To isolate and
characterise the mouse ortholog of the human OPA1
gene, we amplified an adult mouse brain cDNA using
primers designed from the human cDNA sequence. 5'
RACE-PCR experiments extended the sequence 238 bp
upstream from the ATG triplet. The comparison of the
RACE-PCR product with the genomic sequence upstream
from the start codon revealed that the newly identified
5'cDNA sequence is contiguous with the previously de-
fined exon 1 in the Opa1 genomic DNA, thereby only ex-
tending exon 1 without forming a new exon. The open
reading frame was found to be 2883 bp in size encoding a
mouse Opa1 protein of 960 amino acids. As in human
OPA1, mouse Opa1 contains a putative mitochondrial
targeting signal, GTPase and dynamin central region do-
mains and two predicted coiled-coil structures (upstream
the GTPase domain and in the C-terminal domain) with
97 % overall identity with the human sequence. Human
and mouse sequences are somewhat divergent in the first
200 N-terminal amino acids (83 % identity) that mostly
contains the mitochondrial leading sequence.
To examine the genomic structure of mouse Opa1 we per-
formed a Blast search against the mouse genomic data-
base with the full-length mouse Opa1 cDNA sequence. A
mouse "working draft" BAC clone was identified that con-
tained the entire mouse Opa1 genomic sequence. By rear-
ranging the sequences in this BAC, the intron/exon
boundaries and most intron sequences of mouse Opa1
were determined. We established that Opa1 consists of 31
exons and 30 introns extending over 68 kb (Fig. 1). We
found that exon/intron boundaries of human and mouse
OPA1 were preserved and followed the GT/AG rule. The
sizes of all exons are remarkably conserved between the
murine and human gene but 16 mouse Opa1 introns are
smaller than human ones. As for the human gene, mouse
Opa1 exhibits 8 transcripts that result from the alternative
splicing of exons 4, 4b and 5b with a predominance of the
transcript without exons 4b and 5b in neuronal tissues
(retina and brain) (Fig. 2).
Figure 1
Genomic structure of mouse Opa1. The bars and numbers represent coding exons and the lines represent introns. Exons 
encoding the different domain of the protein are in brackets. The 5' UTR and the 3' UTR (white bar) are indicated. The con-
served region in intron 8 is indicated with an asterisk.
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In search for conserved putative regulatory sequences, we
performed a comparative analysis of the Opa1 introns. We
found small conserved regions (ranging from 50 to 155
bp in length) in almost all introns but the largest homol-
ogous fragment was found in intron 8. This 155 bp-long
fragment is 79% identical in both species and covers 1/3
of the intron length. Polymorphisms IVS8 + 4 C/T and
IVS8 + 32 T/C putatively involved in normal tension glau-
coma [29] are located upstream of this fragment. We se-
quenced this fragment in DOA patients (n = 3) who had
no mutations in the exons and splice junctions of OPA1
and found no mutations.
Promoter regions of mouse and human Opa1
Comparison of the 5'genomic sequences of mouse and
human genes revealed a 26 bp-long stretch that exhibits
80 % homology (as found for the rest of exon 1) and lies
next to the 5' limit of our RACE-PCR sequence (Fig. 3). It
is possible that this stretch corresponds to the 5' end of the
mRNA that could have been missed by the RACE-PCR ex-
periment. Mouse and human upstream regions did not
contain any binding sites for RNA polymerase II core pro-
moter elements such as CAAT and TATA boxes. This was
not unexpected since TATA boxes are found in only 32 %
of the promoters [30]. However, we did found several
conserved GC boxes, 3 in mouse and 2 in human se-
quences, that are binding sites for the SP1 transcription
activator (Fig. 3). The presence of these GC boxes is typical
of housekeeping gene promoters, corroborating previous
findings showing ubiquitous expression of OPA1 [15,16].
A sequence matching Nuclear Factor 1 (NF1) binding site
was also identified and conserved between human and
mouse. As for GC boxes, genes regulated by NF1 proteins
are widely expressed.
Mutation screening of Opa1 in Bst mouse
Because OPA1 mutations presumably cause the degenera-
tion of retinal ganglion cells in DOA, we evaluated it as a
candidate gene in the mutant mouse Bst which is
phenotypically comparable to the DOA in man [24,25].
Indeed, both OPA1 and Bst mutations are inherited as
dominant phenotypes with variable expressivity, and
both target the retinal ganglion cells. We therefore se-
quenced the entire cDNA, the genomic DNA (exons and
flanking sequences) and the putative promoter region of
Opa1 in Bst/+ heterozygous mice and in the +/+ back-
ground strain. No mutation was detected in the coding re-
gion or intron/exon boundaries. No deletion was detected
by amplification of the full length cDNA. This virtually ex-
cluded point mutations in amino acid coding sequences
and in splice site regions but large deletions or mutations
present in unexplored regions of the gene were still
possible.
Mapping of mouse Opa1 to chromosome 16 in a region 
distinct from the Bst locus
Using radiation hybrid mapping, we found that Opa1 is
located on chromosome 16 between genetic markers
D16Mit3 and D16Mit124, 10.09 cR distal to the marker
D16Mit3 (lod>3) which correspond to 20.9 cM from the
centromere (Fig. 4). Previous studies have mapped the Bst
locus to mouse chromosome 16, 1.9+/- 1.1 cM from
D16Mit168 [25,27]. In order to compare the location of
D16Mit168 on genetic map with the physical map devel-
oped with the T31 radiation hybrid panel, we mapped the
marker D16Mit168 with the T31 RH panel and found it at
2.12 cR from D16Mit113, which is approximately at 33
cM from the centromere. This position fits with the
location of this marker on the consensus map for mouse
Chromosome 16 at 30 cM from the centromere [28]. Ac-
cording to the placement of D16Mit168, Bst lies approxi-
mately 31.5 cM from the centromere, in a region syntenic
with human 3q13. In the integrated genetic map, Opa1
locus is approximately 10 cM centromeric to the Bst locus,
indicating that Opa1 and Bst are not allelic. This excludes
Opa1 as the candidate gene for the Bst mutant mouse and
shows that the Bst mouse is not the corresponding animal
model for DOA.
The exclusion of Opa1 from the Bst locus is in accordance
with some phenotypic discrepancies between the DOA
patients and Bst mice. Indeed, there are a variety of organs
consistently affected by the Bst mutation. The Bst mouse
is smaller than its normal counterpart, shows
depigmentation of hair and exhibits numerous skeletal
Figure 2
RT-PCR analysis demonstrating multiple Opa1 tran-
scripts in mouse tissues. Use of ME3S and MK5bAS prim-
ers resulted in the amplification of 6 distinct fragments, the 
size of which is indicated on the left. RT-PCR was performed 
on mouse lung (lane 1), kidney (lane 2), brain (lane 3), liver 
(lane 4), testis (lane 5), retina (lane 6) spleen (lane 7) and 
H2O (lane 8).
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abnormalities attributed to developmental delay: poly-
dactyly of fingers and toes and a short kinked tail [26]. In
addition, some Bst mice have colobomas of the optic
nerve and retina with subretinal neovascularisation [31],
which is never seen in DOA patients. These defects suggest
that the normal Bst gene is essential to development and
may regulate cellular differentiation during organogene-
sis. Nevertheless the mitochondrial origin of the Leber
Hereditary optic atrophy, DOA type OPA1 and Type III 3-
Methylglutaconic Aciduria (Costeff optic atrophy syn-
drome) suggests that the Bst gene could encode a mito-
chondrial protein [32]. Moreover, a mutation in a
mitochondrial transmembrane protein has been de-
scribed in a mouse with flexed tail, white belly spots and
skeletal abnormalities resembling the Bst phenotype [33].
We found a human gene, TOMM70A (OMIM#606081)
that encode a translocase of the outer mitochondrial
membrane and that map to 3q12.3 in the syntenic region
of the Bst locus. We sequenced the full genomic DNA of
the Tom70 mouse homolog of Bst mice and found no
changes, thereby excluding also this gene as the Bst gene.
Conclusions
In this work, we report the genomic structure and the po-
sition of the mouse Opa1 gene by radiation hybrid map-
ping. The exclusion of the Opa1 candidate gene for the Bst
phenotype suggests that the Bst mouse was not the mouse
model of DOA. Considering these data, the development
Figure 3
Comparison of the genomic sequence upstream of the human and mouse OPA1 gene. The transcribed sequence is 
shown in capital letters. Asterisk indicates the 5' limit found by RACE-PCR and highlighted in grey is the conserved sequence 
that may represent the actual 5' end of the mRNA. The initiation codon for translation (ATG) is in bold. Putative binding sites 
conserved between human and mouse as identified by computer searches are shown with horizontal bars on top of the 
sequence line.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/8
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of a mouse model will permit further understanding of
Opa1 function and the study of the pathophysiological
mechanisms of DOA, as well as the future evaluation of
treatment strategies for the disease.
Methods
RNA and DNA purification
The mouse strains C57BLKS (control) and C57BLKS Bst/+
(heterozygous belly spot and tail) were purchased from The
Jackson Laboratory (Bar Harbor, ME). Adult Bst/+ mice ex-
hibit a kinked tail and a white belly spot. Total RNA of var-
ious tissues was extracted with the Rneasy kit (Qiagen,
Germany) following the manufacturer's instructions. First
strand cDNA synthesis was performed with Super Script II
reverse transcriptase (Invitrogen, The Netherlands) using
1 µg of RNA and 50 pmol of random primers (Promega,
USA). DNA was isolated from tail snips by standard
methods.
DNA amplification
Genomic DNA and overlapping RT-PCR products were
amplified under standardised conditions as follows: de-
naturation at 94°C for 3 min followed by 35 cycles of 30
sec at 94°C, 30 sec at 62°C, 1 min at 72°C and a final
elongation at 72°C for 10 min. Each PCR fragment was
purified using the Qiaquick purification kit (Qiagen, Ger-
many) and sequenced on an ABI 310 capillary sequencer
(Applied Biosystems, USA). The alternatively spliced tran-
Figure 4
Mouse Opa1 mapped to Chromosome 16 outside the Bst interval. On the WG-RH mapping panel T31 (left diagram), 
mouse Opa1 locus maps to Chromosome 16 between genetic markers D16Mit3 and D16Mit124. On the integrated genetic 
map (middle diagram) prepared from the mouse gene database (Mouse Chromosome 16 Linkage Map: http://informat-
ics.jax.org/searches/linkmap_form.shtml), Opa1 mapped 10 cM centromeric to Bst locus. Analysis of human syntenic regions of 
Opa1 and of the Bst locus (right diagram) indicates that the Bst locus (the synteny of which being unknown, question mark) is 
flanked by human 3q13 syntenic regions.
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scripts of mouse Opa1 were amplified in several tissues
(lung, kidney, brain, liver, testis, retina and spleen) using
primers located in exon 3 (ME3S: 5'-GTGACTATAAGT-
GGATTGTGCCT-3') and in exon 7 (MK5BAS: 5'-CGCTC-
CAAGATCCTCTGATAC-3'). The obtained RT-PCR
products were cloned into the pGEM-T vector (Promega,
USA) and sequenced using primers M13F and M13R. The
5'-untranslated region of Opa1 was obtained by RACE-
PCR amplification of cDNA sequences generated from
brain mRNA (GeneRacer Kit, Invitrogen, The
Netherlands) according to the manufacturer's instruc-
tions. The gene-specific primer B9AS (5'-AAGAGTCTT-
GCAGCTAACCTTGC-3') located in exon 2 was used for
the initial reverse transcription. The second PCR was per-
formed with the provided GeneRacer 5' nested primer and
a nested gene-specific primer located in the 5' region of
exon 2 (B8AS: 5'-TTGAAGCTTGAGGGCAGGATGAT-3').
PCR products were then subcloned in the pPCR4Blunt-
TOPO vector (Invitrogen, The Netherlands) and se-
quenced using the nested gene-specific primer.
Radiation hybrid mapping
The 100 radiation hybrid (RH) DNAs of the T31 mouse/
hamster RH panel [34] (Research Genetics, USA) were
used as templates for PCR amplification of Opa1  and
D16Mit168, this marker being close to the Bst  locus
[26,27]. For Opa1, we designed forward (MK5S: 5'-TT-
GCCAGTTTAGCTCCCGACTT-3') and reverse (MK6AS: 5'-
CAGATCCATGATCTGTTGCTCG-3') primers to amplify a
1438-bp PCR fragment from mouse genomic DNA. No
fragment was obtained when hamster genomic DNA was
subjected to amplification. For the D16Mit168 marker, we
used forward (D16Mit168F: 5'-TGTGGTAGATGGA-
TAAAAGAATGTG-3') and reverse (D16Mit168F: 5'-CAT-
GGAGAAGTTCCTGTAAGCA-3') primers to amplify a
152-bp amplicon. No signal was detected from hamster
DNA amplification. The results were submitted to the
linkage database at the Whitehead Institute/MIT Center
for Genome Research http://www.genome.wi.mit.edu.
Sequence analysis
The human and mouse putative promoter regions were
compared by BLAST2 sequences [35]. Potential transcrip-
tion regulatory sites were detected using the MatInspector
program http://transfac.gbf.de/cgi-bin/matSearch/mats-
earch.pl as implemented by the Baylor College of Mede-
cine Search Launcher. This software accesses the
TRANSFAC MATRIX database which contains the consen-
sus binding sites for a variety of transcription factors.
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